Medicare's Biosimilar Pay Policy Draws Congressional Fire
Lawmakers on Thursday trained bipartisan fire on plans to cut Medicare's costs for biosimilars, questioning whether it will discourage development of the copycat medicines....To view the full article, register now.
Already a subscriber? Click here to view full article